The molecular landscape of LM can differ from its primary tumor [39]; for instance a patient with gastric cancer LM had CSF CTCs with nine identified mutations, four that were seen in the patient’s primary tumor, and five additional mutations in MDM2, TP53, KRAS, STK11, and ALK. This evidence concerns the gene KRAS and neoplasm.